Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.（ESPR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ESPR · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
17
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Esperion Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ESPR 季度内部人买卖趋势
ESPR 内幕交易卖出 · ESPR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ESPR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ESPR 高管卖出股份 · ESPR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 28, 2026 | THOMPSON JOHN CRAIG Director | Award | 79,873 | — | Form 4 |
| May 28, 2026 | Shepard Jay Director | Award | 79,873 | — | Form 4 |
| May 28, 2026 | Hoffman Robert E. Director | Award | 79,873 | — | Form 4 |
| May 28, 2026 | Fischer Seth H. Z. Director | Award | 79,873 | — | Form 4 |
| May 28, 2026 | CARROLL J MARTIN Director | Award | 79,873 | — | Form 4 |
| Mar 17, 2026 | Looker Benjamin Chief Legal Officer | Sale | 5,708 | $15K | Form 4 |
| Mar 17, 2026 | Koenig Sheldon L. President and CEO · Director | Sale | 25,578 | $70K | Form 4 |
| Mar 17, 2026 | Halladay Benjamin CFO | Sale | 6,424 | $17K | Form 4 |
| Mar 13, 2026 | Looker Benjamin Chief Legal Officer | Award | 300,840 | — | Form 4 |
| Mar 13, 2026 | Koenig Sheldon L. President and CEO · Director | Award | 723,760 | — | Form 4 |
| Mar 13, 2026 | Halladay Benjamin CFO | Award | 247,430 | — | Form 4 |
| Jan 20, 2026 | Looker Benjamin General Counsel | Sale | 1,689 | $5K | Form 4 |
| Dec 17, 2025 | Koenig Sheldon L. President and CEO · Director | Sale | 48,244 | $177K | Form 4 |
| Dec 17, 2025 | Halladay Benjamin CFO | Sale | 7,337 | $27K | Form 4 |
| Dec 17, 2025 | Looker Benjamin General Counsel | Sale | 6,517 | $24K | Form 4 |
| Dec 4, 2025 | Harlow John B. Jr. Chief Commercial Officer | Award | 424,536 | — | Form 4 |
| Sep 17, 2025 | Looker Benjamin General Counsel | Sale | 6,267 | $18K | Form 4 |
| Sep 17, 2025 | Koenig Sheldon L. President and CEO · Director | Sale | 28,427 | $79K | Form 4 |
| Sep 17, 2025 | Halladay Benjamin CFO | Sale | 7,046 | $20K | Form 4 |
| Jul 17, 2025 | Looker Benjamin General Counsel | Sale | 1,304 | $1K | Form 4 |
| Jul 17, 2025 | Halladay Benjamin CFO | Sale | 11 | $12 | Form 4 |
| Jun 17, 2025 | Looker Benjamin General Counsel | Sale | 6,422 | $7K | Form 4 |
| Jun 17, 2025 | Koenig Sheldon L. President and CEO · Director | Sale | 30,474 | $34K | Form 4 |
| Jun 17, 2025 | Halladay Benjamin CFO | Sale | 7,229 | $8K | Form 4 |
| May 29, 2025 | CARROLL J MARTIN Director | Award | 33,000 | — | Form 4 |
Koenig Sheldon L.
President and CEO · Director
日期
Mar 17
股数
25,578
均价
$2.72
总金额
$70K
Koenig Sheldon L.
President and CEO · Director
日期
Dec 17
股数
48,244
均价
$3.67
总金额
$177K
Koenig Sheldon L.
President and CEO · Director
日期
Sep 17
股数
28,427
均价
$2.79
总金额
$79K
Koenig Sheldon L.
President and CEO · Director
日期
Jun 17
股数
30,474
均价
$1.11
总金额
$34K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ESPR 内幕交易
ESPR 内幕交易
Esperion Therapeutics, Inc.（ESPR）内幕交易数据来源于公司内部人（包括Looker Benjamin (Chief Legal Officer), Halladay Benjamin (CFO), Koenig Sheldon L. (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ESPR内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Esperion Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ESPR 内幕交易 · 5个问题Esperion Therapeutics, Inc.（ESPR）的内部人包括高管和董事，如Looker Benjamin (Chief Legal Officer), Halladay Benjamin (CFO), Koenig Sheldon L. (President and CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026